Paper Details

  1. Home
  2. Paper Details

Pilot study on adjuvant chemotherapy and hormonal therapy for irradiated inoperable breast cancer.

Author: EngelsmanE, HamersmaE, SchaakeC

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A pilot study of adjuvant chemotherapy and hormonal therapy for inoperable breast cancer found that the treated group showed a better relapse-free survival than the control group, particularly for premenopausal women. However, there was no significant difference in overall survival between the groups.
Paper Details　
Original Abstract of the Article :
A pilot study of adjuvant chemotherapy and hormonal therapy for inoperable breast cancer was performed. The patients were known to have a bad prognosis because of occult generalized disease. At the time of first treatment, the patients selected showed no signs of systemic disease. Local control of t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/978-3-642-81332-0_16

データ提供：米国国立医学図書館（NLM）

Adjuvant Therapy for Inoperable Breast Cancer: A Pilot Study

The fight against breast cancer requires a multi-pronged approach, including adjuvant therapies to improve outcomes. This pilot study investigates the efficacy of adjuvant chemotherapy and hormonal therapy in patients with inoperable breast cancer. The researchers explored the potential benefits of this combined approach, aiming to improve relapse-free survival and overall survival.

A Glimpse of Potential: Early Results

The study found that patients receiving adjuvant chemotherapy and hormonal therapy showed a better relapse-free survival compared to a control group. This suggests that this combined approach may have a positive impact on disease control. However, the researchers acknowledge that further research is needed to confirm these findings and to determine the long-term effects of this treatment strategy.

The Evolving Landscape of Breast Cancer Treatment

The study highlights the ongoing evolution of breast cancer treatment. The initial pilot study paved the way for larger, randomized controlled trials to further investigate the efficacy of adjuvant therapy in inoperable breast cancer. This ongoing research is crucial for advancing treatment strategies and improving patient outcomes in the battle against this formidable disease.

Dr.Camel's Conclusion

This pilot study provides a promising glimpse into the potential benefits of adjuvant chemotherapy and hormonal therapy in inoperable breast cancer. While further research is needed to confirm these findings, this study underscores the importance of exploring new and innovative treatment approaches to combat this challenging disease. The desert of breast cancer research continues to evolve, and ongoing exploration is essential for discovering new paths to victory.
Date :
  1. Date Completed 1979-09-27
  2. Date Revised 2019-09-02
Further Info :

Pubmed ID

379929

DOI: Digital Object Identifier

10.1007/978-3-642-81332-0_16

Related Literature

Article Analysis
・Effective treatment of breast cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.